Windlas Biotech Limited — Board Meeting, 22-05-2025: Outcome of Board Meeting

Windlas Biotech has announced a board meeting on May 22, 2025, approving the audited consolidated financial results for the quarter and year ended March 31, 2025. The company posted revenue of Rs. 759.88 Cr and profit after tax of Rs. 60.99 Cr, with an EPS of Rs. 29.19. A dividend of Rs. 5.80 per share was proposed. Windlas launched the ‘Windlas Plan 2025’ ESOP scheme, offering 5.9 lakh options pending shareholder nod. Its joint venture USpharma Windlas LLC was shut down during the year.